HFS
CSTL icon

Hughes Financial Services’s Castle Biosciences CSTL Stock Holding History

Hughes Financial Services’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.4K Sell
436
-10
-2% -$223 ﹤0.01% 364
2026
Q1 		$10.9K Buy
446
+10
+2% +$328 ﹤0.01% 314
2025
Q4 		$17K Buy
436
+1
+0.2% +$32 ﹤0.01% 242
2025
Q3 		$15.1K Hold
435
– – ﹤0.01% 252
2025
Q2 		$8.6K Hold
435
– – ﹤0.01% 329
2025
Q1 		$8.6K Buy
+435
New +$10.8K ﹤0.01% 340

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hughes Financial Services's CSTL Position: Q2 2026 in Review

Hughes Financial Services reduced its Castle Biosciences (CSTL) stake by 2.2% in Q2 2026, selling an estimated $223 and leaving 436 shares worth $10.4K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

Hughes Financial Services first reported a position in CSTL in Q1 2025 and has held it in 6 quarters since. The position peaked at $17K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Hughes Financial Services held 436 shares of Castle Biosciences worth $10.4K as of Q2 2026.
  • Hughes Financial Services sold 10 Castle Biosciences shares in Q2 2026, an estimated $223.
  • Castle Biosciences made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #364 holding.
  • Hughes Financial Services first reported a position in Castle Biosciences in Q1 2025 and has held it in 6 quarters since.
  • Hughes Financial Services's Castle Biosciences position peaked at $17K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.